Updating the Strategy on Traditional Medicine

In 2009 the Sixty-second World Health Assembly adopted resolution WHA62.13, requesting the Director-General, inter alia, to update the WHO traditional medicine strategy: 2002–2005, based on countries’ progress and current new challenges in the field of traditional medicine.

In line with resolution WHA62.13, WHO organized a broad consultative process, convening experts, Member States and other stakeholders across the six WHO regions to develop the strategic objectives, directions and actions for an updated strategy on traditional medicine for the period 2014–2023.

Continue reading PDF

By Bismah Malik, May 16, 2016

Indian government and the World Health Organization (WHO) have signed a Project Collaboration Agreement (PCA) for promotion of traditional medicines, an official statement by the ministry of AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy) released on Saturday said. The agreement was signed between Ajit M Sharan, secretary at ministry of AYUSH, and Marie Kieny, assistant director general of health systems and innovations at WHO, in Geneva on 13 May in the presence of Shripad Yesso Naik, minister of state (AYUSH), and Margaret Chan, director-general at WHO.

The PCA is titled "Co-operation on promoting the quality, safety and effectiveness of service provision in traditional and complementary medicine between WHO and AYUSH, India, 2016-2020." It aims at supporting WHO in the development and implementation of the "WHO Traditional and Complementary Medicine Strategy: 2014-2023" and will contribute to the global promotion of traditional Indian Systems of Medicine, according to the statement. It also envisages to promote and integrate traditional medicines in the national healthcare systems and will deliver for the first time WHO benchmark document for training in Yoga, and for practice in Ayurveda, Unani and Panchakarma. While commenting on the agreement, an AYUSH minister said that the initiatives undertaken by India in traditional medicines sector align with the WHO Traditional Medicine Strategy 2014-2023. The PCA will enable India's long-term collaboration with the WHO in the global promotion and integration of AYUSH systems of medicine by including Ayurveda and Unani in the international classification of diseases and the international classification of health interventions, according to the statement. India had earlier partnered with the United States to devise cancer treatment through traditional medicines during the two-day U.S.-India workshop on traditional medicines (March 3-4), which was attended by researchers from both the countries.

From: International Business Times

In contrast to the EU, the WHO is very active in the field of CAM:

The responsible department for TM under the leadership of Dr. Zhang Qi, may not have a lot of personnel, but it has already accomplished much: seven benchmarks, over 100 plant monographs, a revised T&CM strategy paper 2014-2023, the development of a TM Diagnostic Key for the new ICD-11-Code System, and the ratified Resolution of 2014. In this year, the general assembly (WHA), of the World Health Organization (WHO), passed a Resolution on Traditional Medicine (TM=T&CM=CAM), through the votes of 194 member states, with numerous European nations among them. In this resolution, the nations were asked to integrate TM in their respective health systems. In addition to other countries, China, Japan, Korea, USA, Australia, Canada and now India, are currently putting this resolution into practice. Governments, universities, health professions and manufacturers are working together and officially supporting a positive political policy towards TM.

At this year’s WHA2016 in May, the creation of a TM Work Group was proposed in which representatives of CAM will participate… 

Antimicrobial resistance (AMR) – the resistance of a microorganism to an antimicrobia drug that was originally effective for treatment of infections caused by it – threatens the effective prevention and treatment of infections caused by bacteria, parasites, viruses and fungi. It is an increasingly serious threat to global public health that requires action across all government sectors and society. This paper describes how the sector of Complementary and Alternative Medicine (CAM) can contribute to reducing the problem of AMR.

The CAM perspective on health and disease is essentially different from the conventional biomedical perspective. It is not just a difference in the technology and instruments used, but in the underlying paradigms, the basic concepts of and philosophical perspective.  Although CΑΜ represents a variety of different medical systems and therapies, the CAM modalities have a common denominator, i.e. their individualised holistic approach and their focus on promoting the individual’s health by assisting the person’s innate healing capacity.
Please read the EUROCAM’s document (PDF)Anhang